Company Filing History:
Years Active: 2013-2015
Title: Innovations by Jie Da in Biodegradable Polymer Compositions
Introduction
Jie Da is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of biodegradable polymer compositions. With a total of two patents to his name, he has made strides in developing materials that are both biocompatible and biodegradable, which are crucial for medical applications.
Latest Patents
Jie Da's latest patents focus on bis-(α-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions. These innovative materials are designed to be biodegradable and biocompatible, making them suitable for various medical applications. The co-polymer compositions can be tailored by selecting different combinations and proportions of building blocks, allowing for customization of mechanical properties. These compositions are particularly useful in the production of drug-releasing biodegradable particles and implantable surgical devices, such as stents and internal fixation devices. The unique feature of these materials is their ability to biodegrade in vivo through enzymatic action, releasing bioactive agents in a controlled manner over time, along with biocompatible breakdown products, including various amino acids.
Career Highlights
Jie Da is currently associated with Medivas, LLC, where he continues to innovate in the field of polymer science. His work has garnered attention for its potential to improve medical devices and drug delivery systems, enhancing patient outcomes through advanced materials.
Collaborations
Throughout his career, Jie Da has collaborated with notable colleagues, including Zaza D Gomurashvili and Jonathan Hughes. These collaborations have contributed to the development of his innovative patents and have fostered a productive research environment.
Conclusion
Jie Da's contributions to the field of biodegradable polymers represent a significant advancement in medical technology. His innovative work continues to pave the way for new applications that can improve patient care and outcomes.